Table 1.
Clinical and pathological characteristics of the UIHC cohort of patients included in this study
| Recurred (N=16) | Not recurred (N=109) | p-value | ||
|---|---|---|---|---|
| Preoperative characteristics | Age (mean) | 65 | 61 | 0.093 |
| BMI (mean) | 31.9 | 36.4 | 0.114 | |
| Charlson Morbidity Index | 5.4 | 5 | 0.271 | |
| Grade | 0.122 | |||
| 1 | 2 | 42 | ||
| 2 | 9 | 39 | ||
| 3 | 5 | 25 | ||
| Level of risk | 0.003 | |||
| Low | 1 | 69 | ||
| High | 15 | 40 | ||
| Postoperative characteristics | Invasion (mean) | 67 | 34 | <0.001 |
| 2009 FIGO Stage | <0.001 | |||
| I | 4 | 89 | ||
| II | 3 | 4 | ||
| III | 8 | 11 | ||
| IV | 1 | 5 | ||
| Lymph nodes (positive) | 6 (50%) | 6 (7%) | <0.001 | |
| Peritoneal Cytology (positive) | 4 (31%) | 8 (8%) | 0.012 | |
| Lymphovascular involvement | 11 (73%) | 19 (20%) | <0.001 | |
| ER (positive) | 9 (82%) | 60 (86%) | 0.706 | |
| PR (positive) | 7 (64%) | 61 (87%) | 0.035 | |
| Type of surgery (MI) | 2 (17%) | 8 (13%) | 0.502 | |
| Postoperative complications | 5 (21%) | 23 (23%) | 0.908 | |
| LOS (days) | 4.9 | 4.3 | 0.723 | |
| Adjuvant treatment (yes) | 10 (63%) | 37 (34%) | 0.017 | |
| Adjuvant radiation (yes) | 5 (31%) | 26 (19%) | 0.264 | |
| Outcomes | Overall survival (5 years) | 17% | 90% | <0.001 |
| Death due to disease | 11 (69%) | 0 (0%) | <0.001 |
Abbreviations: UIHC, University of Iowa Hospitals and Clinics; BMI, body mass index; FIGO, International Federation of Gynecology and Obstetrics; ER, estrogen receptor positive; PR, progesterone receptor positive; MI, minimally invasive; LOS, length of stay.